Aurélien Corroyer‐Dulmont

Inactivation of the HIF-1α/PDK3 Signaling Axis Drives Melanoma toward Mitochondrial Oxidative Metabolism and Potentiates the Therapeutic Activity of Pro-Oxidants

Jérôme Kluza, Paola Corazao-Rozas, Yasmine Touil et al. · Cancer Research · 2012 · 147 citations

Medicine, Oncology, Pharmacology +17

Hypoxia induces macrophage polarization and re-education toward an M2 phenotype in U87 and U251 glioblastoma models

M.M. Leblond, Aurélie N. Gérault, Aurélien Corroyer‐Dulmont et al. · OncoImmunology · 2015 · 101 citations · Full text

Medicine, Cell Biology, Oncology +17

Artificial intelligence-based PET denoising could allow a two-fold reduction in [18F]FDG PET acquisition time in digital PET/CT

Kathleen Weyts, Charline Lasnon, Renaud Ciappuccini et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2022 · 58 citations · Full text

Medicine, Nuclear Medicine, Radiology +17

Detection of glioblastoma response to temozolomide combined with bevacizumab based on µMRI and µPET imaging reveals [18F]-fluoro-l-thymidine as an early and robust predictive marker for treatment efficacy

Aurélien Corroyer‐Dulmont, Elodie A. Pérès, Edwige Petit et al. · Neuro-Oncology · 2012 · 52 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

VCAM-1 targeted alpha-particle therapy for early brain metastases

Aurélien Corroyer‐Dulmont, Samuel Valable, Nadia Falzone et al. · Neuro-Oncology · 2019 · 43 citations · Full text

Medicine, Oncology, Radiation Oncology +17